CTSA INFRASTRUCTURE FOR AIDS RESEARCH
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
批准号:
8365250
负责人:
Richard J. Barohn
金额:
$9.57万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-06-01 至 2012-02-29
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject represents an estimate of the percentage of the CTSA funding that is
being utilized for a broad area of research (AIDS research, pediatric research, or
clinical trials). The Total Cost listed is only an estimate of the amount of CTSA
infrastructure going towards this area of research, not direct funding provided by
the NCRR grant to the subproject or subproject staff.
The University of Kansas Heartland Institute for Clinical and Translational Research (HICTR) was established in 2007 in response to the national CTSA initiative. The vision of the HICTR is to improve the health of Kansans by creating a novel and transformative translational research enterprise from bench to bedside to community. Particular strengths of our HICTR program are an entrepreneurial drug and device discovery and development program and a well-developed and highly accomplished community-based research program. The specific aims of the HICTR are to: 1) create a new academic home with innovative training programs for clinical and translational Investigators; 2) provide an enhanced coordinated translational research infrastructure; and 3) actively engage the community in developing, testing, and disseminating research, by capitalizing on and expanding existing networks, to improve the health of all Kansans¿especially those in rural, underserved and other target communities. The proposed infrastructure and educational programs of the HICTR will address the challenges facing clinical and translational investigators by enhancing and integrating existing resources for easier access, developing new innovative resources, and capitalizing on resources residing in research centers across the university¿including our KINBRE and five COBRE grants~and our HICTR network institutions. In support of our aims, we have marshaled an impressive array of institutional, corporate, and community resources in planning, developing, and establishing the HICTR. The HICTR will provide new infrastructure and training and educational programs to support investigators' clinical and translational research¿taking laboratory discoveries to first trials in humans (Tl research) and moving research through to studies on dissemination and implementation of research findings to practice (T2 research). With extraordinary institutional and community support, we already have made tremendous progress. Funding from the CTSA program will allow the University of Kansas' HICTR the opportunity to fully realize its potential not only for our region, but also to contribute to the national CTSA Consortium.RELEVANCE (See Instructions): The University of Kansas Heartland Institute for Clinical and Translational Research is an academic home for clinical and translational research, providing support to scientists and involving the community, so that discoveries and research findings wi|l be brought more rapidly to the point of care, thus improving the health of all Kansans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Frontiers: University of Kansas Clinical and Translational Science Institute
-
批准号:9560956
-
项目类别:
-
资助金额:$402.38万
-
财政年份:2017
-
负责人:Richard J. Barohn
-
依托单位:
Frontiers: University of Kansas Clinical and Translational Science Institute
-
批准号:9514338
-
项目类别:
-
资助金额:$406.37万
-
财政年份:2017
-
负责人:Richard J. Barohn
-
依托单位:
Models of Neuromuscular Disease Across the Lifespan
-
批准号:9195818
-
项目类别:
-
资助金额:$1.6万
-
财政年份:2016
-
负责人:Richard J. Barohn
-
依托单位:
A Phase II Trial of Rituximab In Myasthenia Gravis
-
批准号:8644497
-
项目类别:
-
资助金额:$130.54万
-
财政年份:2013
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2B Trial of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
-
批准号:8569903
-
项目类别:
-
资助金额:$14.5万
-
财政年份:2013
-
负责人:Richard J. Barohn
-
依托单位:
A Phase II Trial of Rituximab In Myasthenia Gravis
-
批准号:8731286
-
项目类别:
-
资助金额:$105.9万
-
财政年份:2013
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2B Trial of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
-
批准号:8683099
-
项目类别:
-
资助金额:$18.5万
-
财政年份:2013
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2B Trial of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
-
批准号:9341908
-
项目类别:
-
资助金额:$21.49万
-
财政年份:2013
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2B Trial of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
-
批准号:10242456
-
项目类别:
-
资助金额:$10.58万
-
财政年份:2013
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
-
批准号:8355588
-
项目类别:
-
资助金额:$39.65万
-
财政年份:2012
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
-
批准号:8543461
-
项目类别:
-
资助金额:$39.04万
-
财政年份:2012
-
负责人:Richard J. Barohn
-
依托单位:
Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis
-
批准号:9132606
-
项目类别:
-
资助金额:$38.44万
-
财政年份:2012
-
负责人:Richard J. Barohn
-
依托单位:
Heartland Unit for Neuroscience Trials
-
批准号:8242137
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
Heartland Institute for Clinical and Translational Research
-
批准号:8270452
-
项目类别:
-
资助金额:$319.78万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
-
批准号:8365247
-
项目类别:
-
资助金额:$185.55万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
Heartland Institute for Clinical and Translational Research
-
批准号:8473932
-
项目类别:
-
资助金额:$310.84万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
HEARTLAND INSTITUTE FOR CLINICAL AND TRANSLATIONAL RESEARCH
-
批准号:8365246
-
项目类别:
-
资助金额:$83.5万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
Heartland Unit for Neuroscience Trials
-
批准号:8337820
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
Heartland Institute for Clinical and Translational Research
-
批准号:8262012
-
项目类别:
-
资助金额:$13.17万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
Heartland Institute for Clinical and Translational Research
-
批准号:8473972
-
项目类别:
-
资助金额:$60.07万
-
财政年份:2011
-
负责人:Richard J. Barohn
-
依托单位:
海外基金